Brief: ISS Recommends Adamis Pharmaceuticals' Stockholders Vote For Critical Proposals At Upcoming Annual Meeting
29/07/2022 13:04
July 29 (Reuters) - Adamis Pharmaceuticals Corp ADMP.O :
* LEADING INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS
ADAMIS
PHARMACEUTICALS’ STOCKHOLDERS VOTE FOR CRITICAL PROPOSALS AT
UPCOMING ANNUAL MEETING
Source text for Eikon: ID:nGNX8zMrYp
Further company coverage: ADMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update